Xeltis CEO, Laurent Grandidier, will provide a keynote lecture at the 2017 Global Investor Forum: Early Phase Start-Up Program. Laurent’s speech will focus on insights into building a successful med-tech company. The Global Investor Forum takes place in Maastricht, the Netherlands, 8-9 February 2017.
“Xeltis is experiencing significant growth and we’re on an exciting, accelerating trajectory. I believe our experience can inspire others on similar journeys” stated Laurent Grandidier.
The Global Investor Forum’s invitation follows Laurent’s six-year transformational experience at Xeltis. Under his leadership, the company transformed from a small research entity to one of the promising medical device companies globally. 2016 marked an exemplary change of pace for Xeltis with its first heart valve in clinical trials, followed by the go ahead from FDA to begin trials in the USA in 2017.
